1. Home
  2. ESPR vs TRVG Comparison

ESPR vs TRVG Comparison

Compare ESPR & TRVG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ESPR
  • TRVG
  • Stock Information
  • Founded
  • ESPR 2008
  • TRVG 2005
  • Country
  • ESPR United States
  • TRVG Germany
  • Employees
  • ESPR N/A
  • TRVG N/A
  • Industry
  • ESPR Biotechnology: Pharmaceutical Preparations
  • TRVG EDP Services
  • Sector
  • ESPR Health Care
  • TRVG Technology
  • Exchange
  • ESPR Nasdaq
  • TRVG Nasdaq
  • Market Cap
  • ESPR 305.0M
  • TRVG 306.5M
  • IPO Year
  • ESPR 2013
  • TRVG N/A
  • Fundamental
  • Price
  • ESPR $1.67
  • TRVG $4.77
  • Analyst Decision
  • ESPR Buy
  • TRVG Hold
  • Analyst Count
  • ESPR 7
  • TRVG 5
  • Target Price
  • ESPR $6.36
  • TRVG $2.94
  • AVG Volume (30 Days)
  • ESPR 4.2M
  • TRVG 109.1K
  • Earning Date
  • ESPR 03-04-2025
  • TRVG 04-29-2025
  • Dividend Yield
  • ESPR N/A
  • TRVG N/A
  • EPS Growth
  • ESPR N/A
  • TRVG N/A
  • EPS
  • ESPR N/A
  • TRVG N/A
  • Revenue
  • ESPR $332,314,000.00
  • TRVG $477,118,749.00
  • Revenue This Year
  • ESPR $5.51
  • TRVG $9.85
  • Revenue Next Year
  • ESPR $1.42
  • TRVG $6.77
  • P/E Ratio
  • ESPR N/A
  • TRVG N/A
  • Revenue Growth
  • ESPR 185.66
  • TRVG N/A
  • 52 Week Low
  • ESPR $1.47
  • TRVG $1.60
  • 52 Week High
  • ESPR $3.94
  • TRVG $5.03
  • Technical
  • Relative Strength Index (RSI)
  • ESPR 48.04
  • TRVG 68.91
  • Support Level
  • ESPR $1.47
  • TRVG $3.90
  • Resistance Level
  • ESPR $1.61
  • TRVG $4.37
  • Average True Range (ATR)
  • ESPR 0.13
  • TRVG 0.35
  • MACD
  • ESPR 0.01
  • TRVG -0.00
  • Stochastic Oscillator
  • ESPR 51.28
  • TRVG 88.81

About ESPR Esperion Therapeutics Inc.

Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.

About TRVG trivago N.V.

trivago NV is a hotel search company focused on reshaping the way travelers search for and compare hotels while enabling hotel advertisers to grow their businesses by providing access to a broad audience of travelers through the company's websites and apps. The platform allows travelers to make informed decisions by personalizing their hotel search and providing access to a deep supply of hotel information and prices. The company operates in three operating segments namely the Americas, Developed Europe, and the Rest of the World. It derives a majority of revenue from the Developed Europe segment. The Developed Europe segment is comprised of Austria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Luxembourg, Malta, the Netherlands, Norway, Portugal, Spain, Sweden, and others.

Share on Social Networks: